Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains.
about
Genetic perspective on the role of the autophagy-lysosome pathway in Parkinson diseaseReduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's diseaseGlucocerebrosidase is shaking up the synucleinopathiesGaucher disease and comorbidities: B-cell malignancy and parkinsonismGlucocerebrosidase and Parkinson disease: Recent advancesGlucocerebrosidase 1 deficient Danio rerio mirror key pathological aspects of human Gaucher disease and provide evidence of early microglial activation preceding alpha-synuclein-independent neuronal cell deathViable neuronopathic Gaucher disease model in Medaka (Oryzias latipes) displays axonal accumulation of alpha-synucleiniPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson's diseaseThe relationship between glucocerebrosidase mutations and Parkinson diseaseGenetics in Parkinson disease: Mendelian versus non-Mendelian inheritanceMitochondrial dysfunction associated with glucocerebrosidase deficiencyLysosomal integral membrane protein-2: a new player in lysosome-related pathologyAmbroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cellsTool compounds robustly increase turnover of an artificial substrate by glucocerebrosidase in human brain lysatesGene-wise association of variants in four lysosomal storage disorder genes in neuropathologically confirmed Lewy body diseaseVisualization of Active Glucocerebrosidase in Rodent Brain with High Spatial Resolution following In Situ Labeling with Fluorescent Activity Based ProbesLysosomal Re-acidification Prevents Lysosphingolipid-Induced Lysosomal Impairment and Cellular ToxicityLIMP-2 expression is critical for β-glucocerebrosidase activity and α-synuclein clearanceMitochondria and quality control defects in a mouse model of Gaucher disease--links to Parkinson's diseaseGlucocerebrosidase modulates cognitive and motor activities in murine models of Parkinson's disease.Behavioral Phenotyping and Pathological Indicators of Parkinson's Disease in C. elegans Models.Factors influencing the measurement of lysosomal enzymes activity in human cerebrospinal fluidOral ambroxol increases brain glucocerebrosidase activity in a nonhuman primate.Macrophage models of Gaucher disease for evaluating disease pathogenesis and candidate drugs.Emerging insights into the mechanistic link between α-synuclein and glucocerebrosidase in Parkinson's diseaseDevelopment of targeted therapies for Parkinson's disease and related synucleinopathiesThe glucocerobrosidase E326K variant predisposes to Parkinson's disease, but does not cause Gaucher's disease.Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutationCerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's diseaseDopaminergic neuronal imaging in genetic Parkinson's disease: insights into pathogenesisLoss of glucocerebrosidase 1 activity causes lysosomal dysfunction and α-synuclein aggregation.A GCase chaperone improves motor function in a mouse model of synucleinopathy.Progressive decline of glucocerebrosidase in aging and Parkinson's disease.Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies.Glucocerebrosidase depletion enhances cell-to-cell transmission of α-synuclein.Gaucher-Associated Parkinsonism.Lysosomal Enzyme Glucocerebrosidase Protects against Aβ1-42 Oligomer-Induced Neurotoxicity.Sustained Systemic Glucocerebrosidase Inhibition Induces Brain α-Synuclein Aggregation, Microglia and Complement C1q Activation in Mice.Glucocerebrosidase activity in Parkinson's disease with and without GBA mutationsHaploinsufficiency of cathepsin D leads to lysosomal dysfunction and promotes cell-to-cell transmission of α-synuclein aggregates
P2860
Q22242985-D630EBF6-46CD-47E4-88AB-D1AF5F974ECFQ24324577-2E38F412-DBBE-4BA9-A88B-D38B1DBF5C6EQ24337392-659C3F4C-FB09-4F93-B21A-618910511E0AQ27002301-2853794E-34B9-460C-94E4-90CE53DA9121Q27005669-FC3981A7-1D91-4FD1-B7B0-9E8B2CD28863Q27300869-D9A5FEEA-774A-4D7F-8591-6C7CE6666A1FQ27311396-16609A56-26B4-4C0A-B86A-695A733E5FB3Q27321433-A361EF38-E2E8-4F89-9B3D-55EC72173256Q28077257-12E8A762-9814-49AC-BBB8-A0D49DDDD034Q28077356-80A0721C-4A8F-49F4-AC70-4B70C40BFEAFQ28115678-15978895-FE08-4B09-9CF5-C7C1180EAC2FQ28305187-B9DC9546-6634-45A1-9654-A6C7D934B445Q28308084-ED0A446C-B41F-433B-BFC9-B30F168EA17BQ28543988-6C66E130-6B00-4821-A6E6-95543B396BC5Q28546902-81BDA83F-6E9D-4938-98E9-C011FB914770Q28548589-3F17D982-1DFB-4ED9-81D5-DA8099BFA4AEQ28555118-4F5F81A0-8538-4346-BBEB-8BAB1D84F66AQ28588670-8E0621CB-8F12-4FAA-A782-F908B3D52813Q28592188-D8E12120-91B6-4B93-A30D-5CA3EE00815DQ30367337-AA046D79-5035-4DCB-B5AA-F16CD40C5733Q33790301-E0A3D5C5-BAD9-4172-8F9A-E6F0299B8606Q33831118-BCC8AC52-911C-4E4C-9DD0-988CBD3F8837Q33835745-6342F972-73A8-4570-8EBE-B45DD980718FQ34165147-EB36DA9E-CA70-47F1-B1DC-141B74A9610FQ34185956-34302597-C8FB-4E88-8272-BDD05F7BE141Q34238616-11A99A31-8E18-4A1E-AAF6-4531DA4D0EB4Q34398442-1206C23A-8C16-4E7C-BAD8-4F6BECD94A99Q34555995-E53DB263-BA03-4C22-BDAA-2EF47C750D1EQ34806122-37700C8B-2BC4-49F0-9EF3-4B00D10CD41FQ34919409-4237A937-71AC-48D1-AA5C-E4673B2BD3C2Q35152964-DA3B3B09-9748-47F2-A9A8-18F219ED8323Q35340158-035466D7-2237-426A-9C3A-1F8D0B37C56DQ35469684-7C8A323C-CD6F-4DBB-B89F-65217CDC1FB7Q35596071-630D06CA-B731-41DA-8FE0-13AB57CF1267Q35674483-0C368080-948E-4391-826C-15E04F00CAC2Q35851610-09722035-449D-4DDD-B977-27C23E5A03EDQ35858682-19D7DC25-C075-42E1-8E64-EE5FAAFC20C2Q35982198-4DC03265-B9A3-46CD-ABEF-E1E5F6290ADDQ36041420-75D9A11E-85A3-4031-A273-B4AC377ED005Q36246469-C20A7EDA-B36E-4981-9EA8-0A96E4F2C9D4
P2860
Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains.
@ast
Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains.
@en
type
label
Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains.
@ast
Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains.
@en
prefLabel
Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains.
@ast
Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains.
@en
P2093
P2860
P50
P356
P1433
P1476
Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains.
@en
P2093
Derek Burke
J Mark Cooper
Simon J R Heales
P2860
P304
P356
10.1002/ANA.23614
P577
2012-09-01T00:00:00Z